Tumor Growth Modeling in Drug Development Tool for Early Phase Decision and Assessment of Response to Therapy

Learn more below.

Previous
Previous

The Quantitative Imaging Biomarker Alliance, Phantoms, and PINTaD

Next
Next

The FDA Approval of 68GA-PSMA-11 PET: An Academic Collaborative Journey